Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TG Therapeutics, Inc. - Common Stock
(NQ:
TGTX
)
53.48
-1.39 (-2.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TG Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic
↗
May 05, 2025
The company, however, raised its full-year 2025 global net revenue target to approximately $575 million, up from its previous guidance of $540 million.
Via
Stocktwits
Earnings Scheduled For May 5, 2025
↗
May 05, 2025
Via
Benzinga
Applying Mark Minervini’s growth stock checklist to TG THERAPEUTICS INC (NASDAQ:TGTX)
↗
May 02, 2025
A fundamental and technical analysis of (NASDAQ:TGTX): Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?
Via
Chartmill
TG Therapeutics Inc (NASDAQ:TGTX): A Strong Minervini Trend Template Candidate
↗
May 01, 2025
TG Therapeutics Inc (NASDAQ:TGTX): A Strong Minervini Trend Template Candidate
Via
Chartmill
Exploring high growth characteristics of TG THERAPEUTICS INC (NASDAQ:TGTX).
↗
April 19, 2025
UA fundamental and technical analysis of (NASDAQ:TGTX): nlocking the high Growth Potential of TG THERAPEUTICS INC (NASDAQ:TGTX).
Via
Chartmill
Price Over Earnings Overview: TG Therapeutics
↗
April 14, 2025
Via
Benzinga
Why TG Therapeutics Stock Was Soaring This Week
↗
March 07, 2025
Via
The Motley Fool
Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts
↗
January 15, 2025
Via
Benzinga
TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
↗
November 25, 2024
Via
Benzinga
Applying Mark Minervini’s growth stock checklist to TG THERAPEUTICS INC (NASDAQ:TGTX)
↗
April 05, 2025
Why TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock. A fundamental and technical analysis of (NASDAQ:TGTX).
Via
Chartmill
IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche
↗
April 02, 2025
The companies both have drugs that treat relapsing forms of multiple sclerosis.
Via
Investor's Business Daily
Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher
↗
March 21, 2025
TG Therapeutics has broken an important resistance level. There is a good chance that they will continue to move higher.
Via
Benzinga
How does TG THERAPEUTICS INC (NASDAQ:TGTX) stack up against Mark Minervini’s strategy?
↗
March 14, 2025
A fundamental and technical analysis of (NASDAQ:TGTX): Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?
Via
Chartmill
TG THERAPEUTICS INC (NASDAQ:TGTX), a growth stock which is not overvalued.
↗
March 10, 2025
Uncover the potential of TG THERAPEUTICS INC, a growth stock reasonably priced. NASDAQ:TGTX is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive...
Via
Chartmill
A Closer Look at TG Therapeutics's Options Market Dynamics
↗
November 21, 2024
Via
Benzinga
NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.
↗
November 21, 2024
NASDAQ:TGTX is showing decent growth, but is still valued reasonably.
Via
Chartmill
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?
↗
March 09, 2025
Top mid-cap stocks jumped up to 23.87%. Some reasons include strong gold/silver, better financial results, and market strength.
Via
Benzinga
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week
↗
March 03, 2025
Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year.
Via
Stocktwits
Stocks Pivot Lower On Trade Fears, Manufacturing Data
↗
March 03, 2025
Despite earlier indicating a strong start to March, stocks are lower this afternoon amid trade war concerns.
Via
Talk Markets
Topics
Stocks / Equities
World Trade
TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide
↗
March 03, 2025
The company has gained notoriety for its multiple sclerosis treatment.
Via
Investor's Business Daily
Topics
Earnings
Earnings Scheduled For March 3, 2025
↗
March 03, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
February 26, 2025
Via
Benzinga
8 Health Care Stocks Whale Activity In Today's Session
↗
January 20, 2025
Via
Benzinga
What's Going On With TG Therapeutics Stock Tuesday?
↗
January 14, 2025
TG Therapeutics Inc (NASDAQ:TGTX) shares are trading higher. The company on Tuesday provided guidance for the fourth quarter and full-year 2024.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
November 12, 2024
Via
Benzinga
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
↗
November 08, 2024
A Fed rate cut and a slew of big earnings reports filled out a busy week.
Via
Investor's Business Daily
Topics
Economy
Government
TG Therapeutics Crashes — Reversing A Breakout — On Its Mixed Third-Quarter Results
↗
November 04, 2024
The company raised its sales outlook for the year, though, following stronger-than-expected revenue from its only product.
Via
Investor's Business Daily
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
↗
November 04, 2024
Via
Benzinga
Napco Security Technologies Posts Downbeat Results, Joins Centrus Energy, Constellation Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
November 04, 2024
Via
Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 04, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
